Clinical Trial Results: Weight Loss & Key Outcomes Phase 2 (Published in NEJM & Nature Medicine) Obesity trial (NEJM 2023): Up to 24.2% mean weight loss at 48 weeks (12 mg dose)
Lemme GLP-1 Daily supports GLP-1 production to reduce hunger, curb cravings, and promote weight management with clinically-studied fruit and saffron extracts
Glutathione injections contain L-Glutathione , a powerful antioxidant composed of amino acids
Food and Drug Administration at the website References DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Juul Holst J, Hu FB, Kahn CR, Raz I, Shulman GI, Simonson DC, Testa MA, Weiss R